Page last updated: 2024-08-25

rosiglitazone and Burns

rosiglitazone has been researched along with Burns in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adanichkin, N; Campbell, JM; Kurmis, R; Munn, Z1
Dülger, GA; Gedik, N; Sehirli, AO; Sener, G1

Reviews

1 review(s) available for rosiglitazone and Burns

ArticleYear
Intensive insulin therapy, insulin sensitisers and insulin secretagogues for burns: A systematic review of effectiveness and safety.
    Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6

    Topics: Burns; Dipeptidyl-Peptidase IV Inhibitors; Disease Management; Exenatide; Glipizide; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Metformin; Pioglitazone; Rosiglitazone; Secretagogues; Sulfonylurea Compounds

2018

Other Studies

1 other study(ies) available for rosiglitazone and Burns

ArticleYear
Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.
    Burns : journal of the International Society for Burn Injuries, 2007, Volume: 33, Issue:5

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Burns; Female; Hypoglycemic Agents; Interleukin-1beta; Kidney Diseases; L-Lactate Dehydrogenase; Liver Diseases; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Urea

2007